| Matthew S Long, CRNA | |
|
17c Brentshire Square, Jackson, TN 38305-2273 | |
| (731) 664-1717 | |
| (731) 664-7114 |
| Full Name | Matthew S Long |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 35 Years |
| Location | 17c Brentshire Square, Jackson, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093707945 | NPI | - | NPPES |
| 3607376 | Medicaid | TN | |
| 1521318 | Medicaid | TN |
| Entity Name | West Tennessee Anesthesia, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427137280 PECOS PAC ID: 8921078312 Enrollment ID: O20040731000339 |
News Archive
Clinical Care Options (CCO), a leader in next-generation medical education, information, and publishing for healthcare professionals, announces a new series of CME/CE-certified interactive local live workshops developed and implemented in partnership with HealthHIV, the leading national HIV nonprofit organization building the capacity of primary care providers to integrate HIV care into their practices.
Since 2010, the number of NHS mental health nurses in England has dropped by 15%. The nursing shortage is partly caused by an ageing workforce that is not being replaced quickly enough. In 2013, more than 32% of mental health nurses were over 50.
Shire plc, the global specialty biopharmaceutical company, announces that the Food and Drug Administration (FDA), following a thorough administrative review of governing statutory and regulatory standards and public comments, has affirmed its prior decision to grant five-year New Chemical Entity (NCE) exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire U.S. Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R).
Nektar Therapeutics today announced positive preliminary initial results from a two-stage Phase 2 clinical study evaluating single-agent NKTR-102 in women with advanced/metastatic breast cancer patients who have received a prior taxane. The increased use of taxanes in breast cancer often renders tumors resistant to these drugs by the time the disease recurs, thereby underscoring the urgent need for new treatment options with novel mechanisms of action for metastatic disease.
An international consortium headed by CAS researchers has identified that the Chinese horseshoe bat is healthy carriers of a virus that is very closely related to those causing SARS (severe acute respiratory syndrome).
› Verified 2 days ago
| Entity Name | Shamrock Community Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033878277 PECOS PAC ID: 8325422082 Enrollment ID: O20220829003239 |
News Archive
Clinical Care Options (CCO), a leader in next-generation medical education, information, and publishing for healthcare professionals, announces a new series of CME/CE-certified interactive local live workshops developed and implemented in partnership with HealthHIV, the leading national HIV nonprofit organization building the capacity of primary care providers to integrate HIV care into their practices.
Since 2010, the number of NHS mental health nurses in England has dropped by 15%. The nursing shortage is partly caused by an ageing workforce that is not being replaced quickly enough. In 2013, more than 32% of mental health nurses were over 50.
Shire plc, the global specialty biopharmaceutical company, announces that the Food and Drug Administration (FDA), following a thorough administrative review of governing statutory and regulatory standards and public comments, has affirmed its prior decision to grant five-year New Chemical Entity (NCE) exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire U.S. Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R).
Nektar Therapeutics today announced positive preliminary initial results from a two-stage Phase 2 clinical study evaluating single-agent NKTR-102 in women with advanced/metastatic breast cancer patients who have received a prior taxane. The increased use of taxanes in breast cancer often renders tumors resistant to these drugs by the time the disease recurs, thereby underscoring the urgent need for new treatment options with novel mechanisms of action for metastatic disease.
An international consortium headed by CAS researchers has identified that the Chinese horseshoe bat is healthy carriers of a virus that is very closely related to those causing SARS (severe acute respiratory syndrome).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew S Long, CRNA 17c Brentshire Square, Jackson, TN 38305-2273 Ph: (731) 664-1717 | Matthew S Long, CRNA 17c Brentshire Square, Jackson, TN 38305-2273 Ph: (731) 664-1717 |
News Archive
Clinical Care Options (CCO), a leader in next-generation medical education, information, and publishing for healthcare professionals, announces a new series of CME/CE-certified interactive local live workshops developed and implemented in partnership with HealthHIV, the leading national HIV nonprofit organization building the capacity of primary care providers to integrate HIV care into their practices.
Since 2010, the number of NHS mental health nurses in England has dropped by 15%. The nursing shortage is partly caused by an ageing workforce that is not being replaced quickly enough. In 2013, more than 32% of mental health nurses were over 50.
Shire plc, the global specialty biopharmaceutical company, announces that the Food and Drug Administration (FDA), following a thorough administrative review of governing statutory and regulatory standards and public comments, has affirmed its prior decision to grant five-year New Chemical Entity (NCE) exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire U.S. Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R).
Nektar Therapeutics today announced positive preliminary initial results from a two-stage Phase 2 clinical study evaluating single-agent NKTR-102 in women with advanced/metastatic breast cancer patients who have received a prior taxane. The increased use of taxanes in breast cancer often renders tumors resistant to these drugs by the time the disease recurs, thereby underscoring the urgent need for new treatment options with novel mechanisms of action for metastatic disease.
An international consortium headed by CAS researchers has identified that the Chinese horseshoe bat is healthy carriers of a virus that is very closely related to those causing SARS (severe acute respiratory syndrome).
› Verified 2 days ago
Robert Wallace, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 367 Hospital Blvd, Jackson, TN 38305 Phone: 731-661-2227 | |
Brendan Mckinney, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 620 Skyline Dr, Jackson, TN 38301 Phone: 731-541-7070 Fax: 731-541-7075 | |
Ryan Shephard, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 620 Skyline Dr, Jackson, TN 38301 Phone: 731-541-7070 Fax: 731-541-7075 | |
Daniel T Hurst, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 810 W Forest Ave, Jackson, TN 38301 Phone: 731-668-1853 Fax: 731-664-7731 | |
Pamela J Austin, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 810 W Forest Ave, Jackson, TN 38301 Phone: 731-662-1853 Fax: 731-664-7731 | |
Jason L. Hooper, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 620 Skyline Dr, Jackson, TN 38301 Phone: 731-541-5000 | |
Margaret Claire Whitehead, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1050 Union University Dr, Jackson, TN 38305 Phone: 901-281-8172 |